Mindbloom
Psychedelic medicine is here
New York, United States · Founded 2018 · $2.0M raised
- Headquarters
- New York, New York
- Employees
- 201–500
- Founded
- 2018
- Business Model
- B2C
- Website
- mindbloom.com
- Total Funding
- $2.0M
- Last Round
- $2.0M SeedJan 2021
- Rounds
- 1
About
Mindbloom is the largest national provider of at-home ketamine therapy for depression, anxiety, and PTSD. Founded in 2018, the company combines clinician-prescribed medicine with 1:1 coaching, group integration circles, and live support. Over 10,000 clients have participated in peer-reviewed clinical studies, with 89% reporting improvement in symptoms.
Summary
Mindbloom is a Digital Health company based in New York, United States, founded in 2018. It has raised $2.0M in total across 1 round, most recently a $2.0M Seed round in Jan 2021. Investors include Long Journey Ventures.
Tech & App Stack
9 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2021
Investors
Similar Companies
Telehealth platform providing personalized health and wellness treatments for men and women, cove...
Workforce mental health platform that uses AI-powered matching to connect employees with high-qua...
Provider of in-home and online pediatric behavioral health and autism care, offering personalized...
National mental-health provider connecting patients to in-network therapists and psychiatric pres...

Coaching, therapy, and psychiatry from the privacy of your smartphone.
Digital therapeutics company providing clinically proven cognitive behavioral therapy programs fo...